← Back to Choate, Hall & Stewart LLP
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19308852 | COMBINATION OF IAP INHIBITORS AND CELLULAR KINASE INHIBITORS, SUCH AS PONATINIB, FOR USE IN THE TREATMENT OF CANCER OR PULMONARY DISEASES, SUCH AS COPD, CYSTIC FIBROSIS, PULMONARY FIBROSIS AND COVID-19 | Tract Pharmaceuticals, Inc. | JARRELL, NOBLE E | 1699 | §103§112 | Final Rejection | — | Pending | Aug 25, 2025 |
| 19283387 | TRANSFER PRINTING STAMPS AND METHODS OF STAMP DELAMINATION | X-Celeprint Limited | FERGUSON SAMRETH, MARISSA LIANA | 2853 | §103 | Non-Final OA | — | Pending | Jul 29, 2025 |
| 19272607 | PROMOTER PROXIMAL SEQUENCES AND USES THEREOF FOR RNA MANUFACTURING | Helix Nanotechnologies Inc. | GONZALES, JOSEPHINE MARIA | 1631 | §103§112 | Final Rejection | 4d overdue | Pending | Jul 17, 2025 |
| 19112201 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | Marvelbiome, Inc. | BREEN, KIMBERLY CATHERINE | 1653 | §101§102§103§112Other | Non-Final OA | 75d | Pending | Mar 14, 2025 |
| 19039502 | SYSTEMS AND METHODS FOR MEASUREMENT AND CONTROL OF SPRAYED LIQUID COVERAGE ON PLANT SURFACES | Agzen Inc. | YANG, JIANXUN | §103 | Non-Final OA | — | Pending | Jan 28, 2025 | |
| 18989413 | STAMPS FOR MICRO-TRANSFER-PRINTING WITH CURVED STAMP POST ENDS | X-Celeprint Limited | KONVES, ADRIANNA N | 1748 | §102§103Other | Final Rejection | — | Pending | Dec 20, 2024 |
| 18986536 | ANTI-PATHOGEN COMPOSITIONS | Claw Biotech Holdings, LLC | TRAN, SUSAN T | 1615 | §102§112Other | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18873573 | NUTRACEUTICAL PARTICLES | Vitakey Inc. | BOATENG, AFUA BAMFOAA | 1617 | §103§112 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18946253 | ELECTRONIC STETHOSCOPE AND DIAGNOSTIC ALGORITHM | Korion Health Inc. | ZHU, QIN | 2691 | §103§112DP | Non-Final OA | — | Pending | Nov 13, 2024 |
| 18883913 | GENERATION OF ACYL AMINO ACIDS | Modular Genetics, Inc. | JONES-FOSTER, ERICA NICOLE | 1656 | §102§103§112DP | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18841541 | FOLDABLE PHYSICAL STRUCTURES | University Of Maine System Board Of Trustees | HIJAZ, OMAR F | 3635 | §102§103 | Final Rejection | — | Pending | Aug 26, 2024 |
| 18835307 | CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS | Insight Molecular Diagnostics Inc. | EVANS, ASHLEY ELIZABETH | 3687 | §101 | Final Rejection | — | Pending | Aug 01, 2024 |
| 18728643 | WEARABLES, METHODS, AND SYSTEMS FOR ALERTING USERS TO HEALTH EMERGENCIES | Echas LLC | MINCHELLA, ADAM ZACHARY | 3794 | §102§103§112 | Non-Final OA | 22d | Pending | Jul 12, 2024 |
| 18771086 | ENCLOSED CAVITY STRUCTURES | X-Celeprint Limited | ARROYO, TERESA M | 2893 | §102§103 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18726861 | COMPOSITIONS AND METHODS FOR INHIBITION OF RAS | Lawrence Livermore National Security, LLC | AGGARWAL, SAHIL CHANDER | 1623 | §112DP | Non-Final OA | — | Pending | Jul 05, 2024 |
| 18721531 | RUMINANT FEED OR SUPPLEMENT FOR RUMINANT FEED AND PROCESS FOR PREPARING THE SAME | Borregaard AS | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18669235 | FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS FOR TREATING ATOPIC DERMATITIS AND FOR IMPROVED STABILITY OF AN ACTIVE PHARMACEUTICAL INGREDIENT | Libertas Bio, Inc. | ROSENTHAL, ANDREW S | 1613 | §103§112 | Final Rejection | 70d overdue | Pending | May 20, 2024 |
| 18710074 | POLYCYCLIC COMPOUNDS AND METHODS THEREOF | Hepaitech (Beijing) Biopharma Technology Co., Ltd. | AULAKH, CHARANJIT | 1629 | §112 | Non-Final OA | — | Pending | May 14, 2024 |
| 18627691 | SYSTEMS AND METHODS FOR FACILITATING LESION INSPECTION AND ANALYSIS | Exini Diagnostics AB | BEKELE, MEKONEN T | 2699 | §102§103 | Final Rejection | 17d overdue | Pending | Apr 05, 2024 |
| 18611068 | DETECTION OF COLORECTAL CANCER | Universal Diagnostics, S.A. | MUMMERT, STEPHANIE KANE | 1637 | §102 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18593039 | TRANSFER-PRINTABLE MICRO-OPTICAL STRUCTURES | X-Celeprint Limited | PENG, CHARLIE YU | 2874 | §102§103 | Final Rejection | — | Pending | Mar 01, 2024 |
| 18584370 | PATTERNED ADHESIVE IN CAVITIES FOR MICRO-TRANSFER PRINTING | X-Celeprint Limited | VALENZUELA, PATRICIA D | 2812 | §103 | Final Rejection | — | Pending | Feb 22, 2024 |
| 18682205 | ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND USES THEREOF | Adimab, LLC | VAN DRUFF, SYDNEY | 1643 | §102§112DP | Non-Final OA | — | Pending | Feb 08, 2024 |
| 18294825 | CELLULOSE NANOFIBER (CNF) STABILIZED MEMBRANES AND METHODS OF MAKING THEREOF | University Of Maine System Board Of Trustees | ORME, PATRICK JAMES | 1779 | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293884 | METHODS FOR REPAIRING CARTILAGE DEFECTS | Vericel Corporation | HU, ANN M | 3774 | §103 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18292859 | IMPROVED CRISPR-CAS TECHNOLOGIES | Sherlock Biosciences, Inc. | HANEY, AMANDA MARIE | 1682 | §102§103DP | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18291432 | COMPOSITIONS AND METHODS FOR INHIBITION OF RAS | TheRas, Inc. | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | — | Pending | Jan 23, 2024 |
| 18576880 | METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES | Olema Pharmaceuticals, Inc. | HIRAKIS, SOPHIA P | 1623 | §103 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18576073 | METHODS | Genetix Biotherapeutics Inc. | TSUI, YUNG-SHENG M | 1684 | §102§103 | Non-Final OA | — | Pending | Jan 02, 2024 |
| 18390483 | MICRO-TRANSFER PRINTING METHODS | X-Celeprint Limited | KARIMY, TIMOR | 2818 | §102§103 | Final Rejection | — | Pending | Dec 20, 2023 |
| 18537754 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | Editas Medicine, Inc. | ROGERS, ERIC JASON | 1638 | §103§112 | Final Rejection | 30d overdue | Pending | Dec 12, 2023 |
| 18537611 | METHODS AND COMPOSITIONS FOR TREATING AND MANAGING ALZHEIMER'S DISEASE | Pharmatrophix, Inc. | PARK, HAEJIN S | 1614 | §102§103§112DP | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18563101 | METHOD OF TREATING ESSENTIAL TREMOR | Cavion, Inc. | FETTEROLF, BRANDON J | 1626 | §103DP | Final Rejection | 14d | Pending | Nov 21, 2023 |
| 18560651 | ADENOVIRAL HELPER PLASMID | Forge Biologics, Inc. | PARAS JR, PETER | 1632 | §102§103§112 | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18285810 | MODIFICATION OF EPOR-ENCODING NUCLEIC ACIDS | Ensoma, Inc. | WHITEMAN, BRIAN A | 1636 | §103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18284959 | COMPOSITIONS AND METHODS FOR INDOOR AIR REMEDIATION | Neoplants SAS | MCWILLIAMS, KELSEY LYNN | 1663 | §103§112DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18551741 | IMMUNE STIMULATING NANOPARTICLE COMPOSITION | Monta Biosciences Aps | ARNOLD, ERNST V | 1626 | §103DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18468681 | NOVEL RECOMBINASES AND METHODS OF USE | Editas Medicine, Inc. | YU, DELPHINUS DOU YI | 1636 | §102§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18244685 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS | Marvelbiome, Inc. | EDWARDS, JESSICA FAYE | 1657 | §112DP | Final Rejection | 5d overdue | Pending | Sep 11, 2023 |
| 18277403 | ANTI-PATHOGENIC LIQUID COMPOSITIONS | Claw Biotech Holdings, LLC | KIM, DANIELLE A | 1613 | §103DP | Final Rejection | 10d overdue | Pending | Aug 16, 2023 |
| 18276110 | NUCLEIC ACID AMPLIFICATION USING PROMOTER PRIMERS | Sherlock Biosciences, Inc. | BAUSCH, SARAE L | 1699 | §102§112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18274754 | CANCER THERAPY | Surge Therapeutics, Inc. | YANG, TIAN | 1674 | §103§112 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18224842 | METHODS OF ALTERING PROTEIN DEPOSITION ON URINARY CATHETERS AND DEVICES | UNIVERSITY OF NOTRE DAME DU LAC | WIECZOREK, MICHAEL P | 1712 | §102§103 | Final Rejection | 26d | Pending | Jul 21, 2023 |
| 18219325 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED PREDICTION OF AMINO ACID SEQUENCES AT A BINDING INTERFACE | Pythia Labs, Inc. | FRUMKIN, JESSE P | 1685 | §102 | Final Rejection | 26d overdue | Pending | Jul 07, 2023 |
| 18345163 | HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY | Bhami'S Research Laboratory, Pvt. Ltd. | KIM, YUNSOO | 1641 | §103§112 | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18216172 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED PREDICTION OF AMINO ACID SEQUENCES | Pythia Labs, Inc. | FRUMKIN, JESSE P | 1685 | §102§112DP | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18268578 | TAXONOMY-INDEPENDENT CANCER DIAGNOSTICS AND CLASSIFICATION USING MICROBIAL NUCLEIC ACIDS AND SOMATIC MUTATIONS | Universal Diagnostics, S.A. | AUGER, NOAH ANDREW | 1687 | §101§103§112 | Final Rejection | 34d | Pending | Jun 20, 2023 |
| 18252709 | CANCER DIAGNOSIS AND CLASSIFICATION BY NON-HUMAN METAGENOMIC PATHWAY ANALYSIS | Universal Diagnostics, S.A. | WISE, OLIVIA M. | 1685 | §101§103§112 | Non-Final OA | — | Pending | May 11, 2023 |
| 18035683 | METHODS | Genetix Biotherapeutics Inc. | WESTON, ALYSSA G | 1633 | §102 | Non-Final OA | 62d | Pending | May 05, 2023 |
| 18142068 | TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS | Olema Pharmaceuticals, Inc. | RODRIGUEZ, RAYNA B | 1628 | Other | Non-Final OA | 62d | Pending | May 02, 2023 |
| 18034139 | TRANSDERMAL DELIVERY | Fount Bio, Inc. | BOSWORTH, KAMI A | 3783 | §102§103 | Non-Final OA | 49d overdue | Pending | Apr 27, 2023 |
| 18023909 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | 64-X, Inc. | GROSS, CHRISTOPHER M | 1684 | §102§112Other | Final Rejection | — | Pending | Feb 28, 2023 |
| 18021634 | IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT | Surge Therapeutics, Inc. | POPA, ILEANA | 1633 | §103§112Other | Final Rejection | 26d overdue | Pending | Feb 16, 2023 |
| 18021231 | DEVICES | Sense Biodetection Limited | MUI, CHRISTINE T | 1797 | §102 | Non-Final OA | 30d | Pending | Feb 14, 2023 |
| 18001340 | GENETIC MODIFICATION | Peter Biotherapeutics, Inc. | LEITH, NANCY J | 1636 | §103 | Non-Final OA | 26d | Pending | Dec 09, 2022 |
| 18009469 | PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | Ferring B.V. | HOWARD, ZACHARY C | 1674 | §103Other | Non-Final OA | — | Pending | Dec 09, 2022 |
| 18073511 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | Marvelbiome, Inc. | REGLAS, GEORGIANA C | 1651 | §112 | Final Rejection | 38d overdue | Pending | Dec 01, 2022 |
| 17982866 | SYSTEMS AND METHODS FOR REAL-TIME MEASUREMENT AND CONTROL OF SPRAYED LIQUID COVERAGE ON PLANT SURFACES | Agzen Inc. | ERDMAN, CHAD G | 2116 | §103 | Non-Final OA | 57d | Pending | Nov 08, 2022 |
| 17980755 | SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING | Universal Diagnostics, S.A. | PHAM, KHAI QUYNH TIEN | 1684 | §103§112 | Final Rejection | 9d | Pending | Nov 04, 2022 |
| 17920385 | COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS | Ned Biosystems, Inc. | WHITE, DAWANNA SHAR-DAY | 1627 | §103Other | Final Rejection | — | Pending | Oct 20, 2022 |
| 17761594 | COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION | Washington University | SINGH, SATYENDRA K | 1657 | §103 | Final Rejection | — | Pending | Oct 11, 2022 |
| 17955346 | HIGH-PRECISION PRINTED STRUCTURES AND METHODS OF MAKING | X-Celeprint Limited | POLLEY, CHRISTOPHER M | 1785 | §103 | Non-Final OA | 18d overdue | Pending | Sep 28, 2022 |
| 17914933 | METHODS FOR PRECISE AND BIAS-FREE QUANTIFICATION OF CELL-FREE DNA | Chronix Biomedical | WILDER, CYNTHIA B | 1681 | §102 | Final Rejection | — | Pending | Sep 27, 2022 |
| 17911678 | A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL | AvenCell Europe GmbH | LEE, YIE CHIA | 1642 | §112 | Non-Final OA | 29d | Pending | Sep 15, 2022 |
| 17909315 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | Aleta Biotherapeutics Inc. | EMCH, GREGORY S | 1678 | §103§112Other | Final Rejection | — | Pending | Sep 02, 2022 |
| 17908941 | METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES | Olema Pharmaceuticals, Inc. | BAUER, NICOLA MARIA | 1621 | §103DP | Non-Final OA | — | Pending | Sep 02, 2022 |
| 17800932 | SYSTEMS AND METHODS FOR LIVE FISH TISSUE PRESERVATION | Finless Foods Inc. | TICHY, JENNIFER M.H. | 1653 | §102§103 | Final Rejection | 81d overdue | Pending | Aug 19, 2022 |
| 17888353 | PROSTATE CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Chronix Biomedical | PHAM, KHAI QUYNH TIEN | 1684 | §101§112Other | Non-Final OA | — | Pending | Aug 15, 2022 |
| 17791785 | COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES | The Sallie Astor Burdine Breast Foundation | BENZION, GARY | 1681 | §103§112 | Non-Final OA | 15d | Pending | Jul 08, 2022 |
| 17850889 | BREAST CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Chronix Biomedical | ZHANG, KAIJIANG | 1684 | §102§112 | Non-Final OA | — | Pending | Jun 27, 2022 |
| 17808868 | TEAD INHIBITORS AND USES THEREOF | Cedilla Therapeutics, Inc. | SEAMAN, D MARGARET M | 1625 | §102§112 | Non-Final OA | — | Pending | Jun 24, 2022 |
| 17786753 | ENGINEERED CELLS FOR THERAPY | Editas Medicine, Inc. | GONZALES, JOSEPHINE MARIA | 1638 | §102§103 | Non-Final OA | 66d overdue | Pending | Jun 17, 2022 |
| 17744231 | METHODS FOR DISEASE DETECTION | Universal Diagnostics, S.A. | CASH, KAILEY ELIZABETH | 1683 | §103§112 | Non-Final OA | 29d | Pending | May 13, 2022 |
| 17766113 | METHODS AND MATERIALS FOR TREATING NEUROTOXICITY | Cavion, Inc. | LEE, CHIHYI NMN | 1628 | §103Other | Final Rejection | — | Pending | Apr 01, 2022 |
| 17706028 | ANTI CD25 FC GAMMA RECEPTOR BISPECIFIC ANTIBODIES FOR TUMOR SPECIFIC CELL DEPLETION | Cancer Research Technology Limited | OUSPENSKI, ILIA I | 1644 | Other | Final Rejection | 57d | Pending | Mar 28, 2022 |
| 17693253 | PRINTING COMPONENTS SUSPENDED BY FRAMES | X-Celeprint Limited | CARLEY, JEFFREY T. | 3729 | §102§103 | Non-Final OA | — | Pending | Mar 11, 2022 |
| 17572403 | CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS | Editas Medicine, Inc. | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | 53d overdue | Pending | Jan 10, 2022 |
| 17503056 | DETECTION AND QUANTIFICATION OF DONOR CELL-FREE DNA IN THE CIRCULATION OF ORGAN TRANSPLANT RECIPIENTS | Chronix Biomedical | KAPUSHOC, STEPHEN THOMAS | 1683 | §103§112DP | Final Rejection | 107d overdue | Pending | Oct 15, 2021 |
| 17599673 | FORMULATIONS | Synchroneuron Inc. | PALENIK, JEFFREY T | 1615 | §103 | Non-Final OA | — | Pending | Sep 29, 2021 |
| 17412608 | CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY | Editas Medicine, Inc. | BABIC, CHRISTOPHER M | 1633 | §103DP | Final Rejection | — | Pending | Aug 26, 2021 |
| 17366830 | CANCER THERAPY | Ned Biosystems, Inc. | TRAN, ERIC | 1629 | §103§112 | Non-Final OA | — | Pending | Jul 02, 2021 |
| 17274948 | PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) INHIBITORS AND USES THEREFOR | Eirion Therapeutics, Inc. | MCANANY, JOHN D | 1625 | §102§103§112DP | Non-Final OA | — | Pending | Mar 10, 2021 |
| 17251447 | REVERSED UNIVERSAL CHIMERIC ANTIGEN RECEPTOR EXPRESSING IMMUNE CELLS FOR TARGETING OF DIVERSE MULTIPLE ANTIGENS AND METHOD OF MANUFACTURING THE SAME AND USE OF THE SAME FOR TREATMENT OF CANCER, INFECTIONS AND AUTOIMMUNE DISORDERS | AvenCell Europe GmbH | COOK, LISA V | 1642 | §103§112DP | Non-Final OA | — | Pending | Dec 11, 2020 |
| 16979515 | DISPERSANT AND BINDER FOR LITHIUM ION BATTERIES BASED ON MODIFIED LIGNIN AND CARBOXYMETHYL CELLULOSE | Borregaard AS | MARTIN, ANGELA J | 1727 | §103§112 | Final Rejection | 14d | Pending | Sep 09, 2020 |
| 16651911 | FORMULATIONS | Intellia Therapeutics, Inc. | BURKHART, MICHAEL D | 1638 | §102§103 | Final Rejection | — | Pending | Mar 27, 2020 |
| 16806536 | RECEPTACLES FOR STAINING AND/OR RINSING SAMPLES AND METHODS OF THEIR USE | Samantree Medical (Switzerland) SA | KUMAR, RAKESH | 3651 | §103§112 | Final Rejection | 3d overdue | Pending | Mar 02, 2020 |
| 16284963 | PROSTATE CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Chronix Biomedical | SITTON, JEHANNE SOUAYA | 1682 | §112DP | Non-Final OA | 44d overdue | Pending | Feb 25, 2019 |
